These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 17907936)

  • 1. Stopping diabetes in its tracks: autologous non-myeloablative stem cell transplantation.
    Fousteri G; Hayek A; von Herrath M
    Regen Med; 2007 Sep; 2(5):845-51. PubMed ID: 17907936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous nonmyeloablative hematopoietic stem cell transplantation in new-onset type 1 diabetes: a multicenter analysis.
    D'Addio F; Valderrama Vasquez A; Ben Nasr M; Franek E; Zhu D; Li L; Ning G; Snarski E; Fiorina P
    Diabetes; 2014 Sep; 63(9):3041-6. PubMed ID: 24947362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus.
    Voltarelli JC; Couri CE; Stracieri AB; Oliveira MC; Moraes DA; Pieroni F; Coutinho M; Malmegrim KC; Foss-Freitas MC; Simões BP; Foss MC; Squiers E; Burt RK
    JAMA; 2007 Apr; 297(14):1568-76. PubMed ID: 17426276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alleviation of exogenous insulin requirement in type 1 diabetes mellitus after immunoablation and transplantation of autologous hematopoietic stem cells.
    Snarski E; Torosian T; Paluszewska M; Urbanowska E; Milczarczyk A; Jedynasty K; Franek E; Jedrzejczak WW
    Pol Arch Med Wewn; 2009 Jun; 119(6):422-6. PubMed ID: 19694226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell-depleted autologous hematopoietic stem cell transplantation for multiple sclerosis: report on the first three patients.
    Burt RK; Traynor AE; Cohen B; Karlin KH; Davis FA; Stefoski D; Terry C; Lobeck L; Russell EJ; Goolsby C; Rosen S; Gordon LI; Keever-Taylor C; Brush M; Fishman M; Burns WH
    Bone Marrow Transplant; 1998 Mar; 21(6):537-41. PubMed ID: 9543056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous hematopoietic stem cell transplantation in type 1-diabetes.
    Rosengren AH; Renström E
    Islets; 2009; 1(1):81-3. PubMed ID: 21084854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematopoietic stem cell transplantation for systemic sclerosis: history and current status.
    Burt RK; Milanetti F
    Curr Opin Rheumatol; 2011 Nov; 23(6):519-29. PubMed ID: 21857226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Independence of exogenous insulin following immunoablation and stem cell reconstitution in newly diagnosed diabetes type I.
    Snarski E; Milczarczyk A; Torosian T; Paluszewska M; Urbanowska E; Król M; Boguradzki P; Jedynasty K; Franek E; Wiktor-Jedrzejczak W
    Bone Marrow Transplant; 2011 Apr; 46(4):562-6. PubMed ID: 20581881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel therapy for type 1 diabetes: autologous hematopoietic stem cell transplantation.
    Li L; Gu W; Zhu D
    J Diabetes; 2012 Dec; 4(4):332-7. PubMed ID: 23190701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor stem cell infusion after non-myeloablative conditioning for tolerance induction to HLA mismatched adult living-donor liver graft.
    Donckier V; Troisi R; Toungouz M; Colle I; Van Vlierberghe H; Jacquy C; Martiat P; Stordeur P; Zhou L; Boon N; Lambermont M; Schandené L; Van Laethem JL; Noens L; Gelin M; de Hemptinne B; Goldman M
    Transpl Immunol; 2004; 13(2):139-46. PubMed ID: 15380544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensive immunosuppression and autologous stem cell transplantation for patients with severe rheumatoid arthritis: the Leiden experience.
    van Laar JM; Verburg RJ; Fibbe WE; Breedveld FC
    J Rheumatol Suppl; 2001 Oct; 64():25-7. PubMed ID: 11642499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive factors for prolonged remission after autologous hematopoietic stem cell transplantation in young patients with type 1 diabetes mellitus.
    Xiang H; Chen H; Li F; Liu J; Su Y; Hao L; Wang F; Wang Z; Zeng Q
    Cytotherapy; 2015 Nov; 17(11):1638-45. PubMed ID: 26318272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis: long-term follow-up of a prospective clinical trial.
    Brinkman DM; de Kleer IM; ten Cate R; van Rossum MA; Bekkering WP; Fasth A; van Tol MJ; Kuis W; Wulffraat NM; Vossen JM
    Arthritis Rheum; 2007 Jul; 56(7):2410-21. PubMed ID: 17599770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological reconstitution after autologous hematopoietic stem cell transplantation in patients with systemic sclerosis: relationship between clinical benefits and intensity of immunosuppression.
    Bohgaki T; Atsumi T; Bohgaki M; Furusaki A; Kondo M; Sato-Matsumura KC; Abe R; Kataoka H; Horita T; Yasuda S; Amasaki Y; Nishio M; Sawada K; Shimizu H; Koike T
    J Rheumatol; 2009 Jun; 36(6):1240-8. PubMed ID: 19447934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensive immunoablation and autologous blood stem cell transplantation in patients with refractory rheumatoid arthritis: the University of Nebraska experience.
    Pavletic SZ; Odell JR; Pirruccello SJ; Ursick MM; Haire CE; Sharp JG; Kessinger A; Klassen LW
    J Rheumatol Suppl; 2001 Oct; 64():13-20. PubMed ID: 11642497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous non-myeloablative haematopoietic stem cell transplantation for refractory systemic vasculitis.
    Statkute L; Oyama Y; Barr WG; Sufit R; Ho S; Verda L; Loh Y; Yaung K; Quigley K; Burt RK
    Ann Rheum Dis; 2008 Jul; 67(7):991-7. PubMed ID: 17947303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful allogeneic stem cell transplantation with fludarabine-based conditioning regimen in severe aplastic anemia.
    Ambulkar I; Parikh PM; Saikia T
    J Assoc Physicians India; 2003 Jul; 51():715-6. PubMed ID: 14621044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Autologous peripheral blood hematopoietic stem cell transplantation in the treatment of type 1 diabetic mellitus: a report of 16 cases].
    Feng K; Xu YW; Ye FG; Xiao L; Ma XH; Gao Y; Zhang X; Yao SZ; Shi BY
    Zhonghua Yi Xue Za Zhi; 2011 Jul; 91(28):1966-9. PubMed ID: 22093891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Non-myeloablative stem cell transplantation for non-malignant hematologic disorders].
    Nakao S
    Nihon Rinsho; 2003 Sep; 61(9):1596-600. PubMed ID: 14515730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.